Medical Care

Global Cold Sore Antiviral Drug Market Research Report 2025

The global market for Cold Sore Antiviral Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cold Sore Antiviral Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold Sore Antiviral Drug.
The Cold Sore Antiviral Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cold Sore Antiviral Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cold Sore Antiviral Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Ortho Dermatologics
Foundation Consumer Healthcare
Novartis
Teva Pharmaceuticals
Amneal Pharmaceuticals LLC
AiCuris
Apotex
Aurobindo Pharma USA, Inc.
Cipla
Glenmark Pharmaceuticals, Inc.
Hikma Pharmaceuticals
HRA Pharma
Hetero Healthcare Ltd
Jubilant Cadista
Merix Pharmaceutical Corp
Sun Pharmaceutical Industries Ltd.
Viatris
Wockhardt
Zydus Pharmaceuticals
Segment by Type
Smear
Oral
Others
Segment by Application
Child
Aldult
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cold Sore Antiviral Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold Sore Antiviral Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Smear
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cold Sore Antiviral Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Child
1.3.3 Aldult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cold Sore Antiviral Drug Market Perspective (2020-2031)
2.2 Global Cold Sore Antiviral Drug Growth Trends by Region
2.2.1 Global Cold Sore Antiviral Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cold Sore Antiviral Drug Historic Market Size by Region (2020-2025)
2.2.3 Cold Sore Antiviral Drug Forecasted Market Size by Region (2026-2031)
2.3 Cold Sore Antiviral Drug Market Dynamics
2.3.1 Cold Sore Antiviral Drug Industry Trends
2.3.2 Cold Sore Antiviral Drug Market Drivers
2.3.3 Cold Sore Antiviral Drug Market Challenges
2.3.4 Cold Sore Antiviral Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold Sore Antiviral Drug Players by Revenue
3.1.1 Global Top Cold Sore Antiviral Drug Players by Revenue (2020-2025)
3.1.2 Global Cold Sore Antiviral Drug Revenue Market Share by Players (2020-2025)
3.2 Global Cold Sore Antiviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cold Sore Antiviral Drug Revenue
3.4 Global Cold Sore Antiviral Drug Market Concentration Ratio
3.4.1 Global Cold Sore Antiviral Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold Sore Antiviral Drug Revenue in 2024
3.5 Global Key Players of Cold Sore Antiviral Drug Head office and Area Served
3.6 Global Key Players of Cold Sore Antiviral Drug, Product and Application
3.7 Global Key Players of Cold Sore Antiviral Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold Sore Antiviral Drug Breakdown Data by Type
4.1 Global Cold Sore Antiviral Drug Historic Market Size by Type (2020-2025)
4.2 Global Cold Sore Antiviral Drug Forecasted Market Size by Type (2026-2031)
5 Cold Sore Antiviral Drug Breakdown Data by Application
5.1 Global Cold Sore Antiviral Drug Historic Market Size by Application (2020-2025)
5.2 Global Cold Sore Antiviral Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cold Sore Antiviral Drug Market Size (2020-2031)
6.2 North America Cold Sore Antiviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cold Sore Antiviral Drug Market Size by Country (2020-2025)
6.4 North America Cold Sore Antiviral Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cold Sore Antiviral Drug Market Size (2020-2031)
7.2 Europe Cold Sore Antiviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cold Sore Antiviral Drug Market Size by Country (2020-2025)
7.4 Europe Cold Sore Antiviral Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold Sore Antiviral Drug Market Size (2020-2031)
8.2 Asia-Pacific Cold Sore Antiviral Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cold Sore Antiviral Drug Market Size (2020-2031)
9.2 Latin America Cold Sore Antiviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cold Sore Antiviral Drug Market Size by Country (2020-2025)
9.4 Latin America Cold Sore Antiviral Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold Sore Antiviral Drug Market Size (2020-2031)
10.2 Middle East & Africa Cold Sore Antiviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Cold Sore Antiviral Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Ortho Dermatologics
11.2.1 Ortho Dermatologics Company Details
11.2.2 Ortho Dermatologics Business Overview
11.2.3 Ortho Dermatologics Cold Sore Antiviral Drug Introduction
11.2.4 Ortho Dermatologics Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.2.5 Ortho Dermatologics Recent Development
11.3 Foundation Consumer Healthcare
11.3.1 Foundation Consumer Healthcare Company Details
11.3.2 Foundation Consumer Healthcare Business Overview
11.3.3 Foundation Consumer Healthcare Cold Sore Antiviral Drug Introduction
11.3.4 Foundation Consumer Healthcare Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.3.5 Foundation Consumer Healthcare Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cold Sore Antiviral Drug Introduction
11.4.4 Novartis Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Cold Sore Antiviral Drug Introduction
11.5.4 Teva Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Amneal Pharmaceuticals LLC
11.6.1 Amneal Pharmaceuticals LLC Company Details
11.6.2 Amneal Pharmaceuticals LLC Business Overview
11.6.3 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Introduction
11.6.4 Amneal Pharmaceuticals LLC Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.6.5 Amneal Pharmaceuticals LLC Recent Development
11.7 AiCuris
11.7.1 AiCuris Company Details
11.7.2 AiCuris Business Overview
11.7.3 AiCuris Cold Sore Antiviral Drug Introduction
11.7.4 AiCuris Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.7.5 AiCuris Recent Development
11.8 Apotex
11.8.1 Apotex Company Details
11.8.2 Apotex Business Overview
11.8.3 Apotex Cold Sore Antiviral Drug Introduction
11.8.4 Apotex Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.8.5 Apotex Recent Development
11.9 Aurobindo Pharma USA, Inc.
11.9.1 Aurobindo Pharma USA, Inc. Company Details
11.9.2 Aurobindo Pharma USA, Inc. Business Overview
11.9.3 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Introduction
11.9.4 Aurobindo Pharma USA, Inc. Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.9.5 Aurobindo Pharma USA, Inc. Recent Development
11.10 Cipla
11.10.1 Cipla Company Details
11.10.2 Cipla Business Overview
11.10.3 Cipla Cold Sore Antiviral Drug Introduction
11.10.4 Cipla Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.10.5 Cipla Recent Development
11.11 Glenmark Pharmaceuticals, Inc.
11.11.1 Glenmark Pharmaceuticals, Inc. Company Details
11.11.2 Glenmark Pharmaceuticals, Inc. Business Overview
11.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Introduction
11.11.4 Glenmark Pharmaceuticals, Inc. Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.11.5 Glenmark Pharmaceuticals, Inc. Recent Development
11.12 Hikma Pharmaceuticals
11.12.1 Hikma Pharmaceuticals Company Details
11.12.2 Hikma Pharmaceuticals Business Overview
11.12.3 Hikma Pharmaceuticals Cold Sore Antiviral Drug Introduction
11.12.4 Hikma Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.12.5 Hikma Pharmaceuticals Recent Development
11.13 HRA Pharma
11.13.1 HRA Pharma Company Details
11.13.2 HRA Pharma Business Overview
11.13.3 HRA Pharma Cold Sore Antiviral Drug Introduction
11.13.4 HRA Pharma Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.13.5 HRA Pharma Recent Development
11.14 Hetero Healthcare Ltd
11.14.1 Hetero Healthcare Ltd Company Details
11.14.2 Hetero Healthcare Ltd Business Overview
11.14.3 Hetero Healthcare Ltd Cold Sore Antiviral Drug Introduction
11.14.4 Hetero Healthcare Ltd Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.14.5 Hetero Healthcare Ltd Recent Development
11.15 Jubilant Cadista
11.15.1 Jubilant Cadista Company Details
11.15.2 Jubilant Cadista Business Overview
11.15.3 Jubilant Cadista Cold Sore Antiviral Drug Introduction
11.15.4 Jubilant Cadista Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.15.5 Jubilant Cadista Recent Development
11.16 Merix Pharmaceutical Corp
11.16.1 Merix Pharmaceutical Corp Company Details
11.16.2 Merix Pharmaceutical Corp Business Overview
11.16.3 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Introduction
11.16.4 Merix Pharmaceutical Corp Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.16.5 Merix Pharmaceutical Corp Recent Development
11.17 Sun Pharmaceutical Industries Ltd.
11.17.1 Sun Pharmaceutical Industries Ltd. Company Details
11.17.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.17.3 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Introduction
11.17.4 Sun Pharmaceutical Industries Ltd. Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.17.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.18 Viatris
11.18.1 Viatris Company Details
11.18.2 Viatris Business Overview
11.18.3 Viatris Cold Sore Antiviral Drug Introduction
11.18.4 Viatris Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.18.5 Viatris Recent Development
11.19 Wockhardt
11.19.1 Wockhardt Company Details
11.19.2 Wockhardt Business Overview
11.19.3 Wockhardt Cold Sore Antiviral Drug Introduction
11.19.4 Wockhardt Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.19.5 Wockhardt Recent Development
11.20 Zydus Pharmaceuticals
11.20.1 Zydus Pharmaceuticals Company Details
11.20.2 Zydus Pharmaceuticals Business Overview
11.20.3 Zydus Pharmaceuticals Cold Sore Antiviral Drug Introduction
11.20.4 Zydus Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.20.5 Zydus Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cold Sore Antiviral Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Smear
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Cold Sore Antiviral Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cold Sore Antiviral Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cold Sore Antiviral Drug Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Cold Sore Antiviral Drug Market Share by Region (2020-2025)
Table 9. Global Cold Sore Antiviral Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Cold Sore Antiviral Drug Market Share by Region (2026-2031)
Table 11. Cold Sore Antiviral Drug Market Trends
Table 12. Cold Sore Antiviral Drug Market Drivers
Table 13. Cold Sore Antiviral Drug Market Challenges
Table 14. Cold Sore Antiviral Drug Market Restraints
Table 15. Global Cold Sore Antiviral Drug Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Cold Sore Antiviral Drug Market Share by Players (2020-2025)
Table 17. Global Top Cold Sore Antiviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Sore Antiviral Drug as of 2024)
Table 18. Ranking of Global Top Cold Sore Antiviral Drug Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Cold Sore Antiviral Drug Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Cold Sore Antiviral Drug, Headquarters and Area Served
Table 21. Global Key Players of Cold Sore Antiviral Drug, Product and Application
Table 22. Global Key Players of Cold Sore Antiviral Drug, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cold Sore Antiviral Drug Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Cold Sore Antiviral Drug Revenue Market Share by Type (2020-2025)
Table 26. Global Cold Sore Antiviral Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Cold Sore Antiviral Drug Revenue Market Share by Type (2026-2031)
Table 28. Global Cold Sore Antiviral Drug Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Cold Sore Antiviral Drug Revenue Market Share by Application (2020-2025)
Table 30. Global Cold Sore Antiviral Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Cold Sore Antiviral Drug Revenue Market Share by Application (2026-2031)
Table 32. North America Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Cold Sore Antiviral Drug Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Cold Sore Antiviral Drug Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Cold Sore Antiviral Drug Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Cold Sore Antiviral Drug Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Cold Sore Antiviral Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Cold Sore Antiviral Drug Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Cold Sore Antiviral Drug Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2026-2031) & (US$ Million)
Table 47. GlaxoSmithKline Company Details
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline Cold Sore Antiviral Drug Product
Table 50. GlaxoSmithKline Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Ortho Dermatologics Company Details
Table 53. Ortho Dermatologics Business Overview
Table 54. Ortho Dermatologics Cold Sore Antiviral Drug Product
Table 55. Ortho Dermatologics Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 56. Ortho Dermatologics Recent Development
Table 57. Foundation Consumer Healthcare Company Details
Table 58. Foundation Consumer Healthcare Business Overview
Table 59. Foundation Consumer Healthcare Cold Sore Antiviral Drug Product
Table 60. Foundation Consumer Healthcare Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 61. Foundation Consumer Healthcare Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Cold Sore Antiviral Drug Product
Table 65. Novartis Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Teva Pharmaceuticals Company Details
Table 68. Teva Pharmaceuticals Business Overview
Table 69. Teva Pharmaceuticals Cold Sore Antiviral Drug Product
Table 70. Teva Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 71. Teva Pharmaceuticals Recent Development
Table 72. Amneal Pharmaceuticals LLC Company Details
Table 73. Amneal Pharmaceuticals LLC Business Overview
Table 74. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product
Table 75. Amneal Pharmaceuticals LLC Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 76. Amneal Pharmaceuticals LLC Recent Development
Table 77. AiCuris Company Details
Table 78. AiCuris Business Overview
Table 79. AiCuris Cold Sore Antiviral Drug Product
Table 80. AiCuris Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 81. AiCuris Recent Development
Table 82. Apotex Company Details
Table 83. Apotex Business Overview
Table 84. Apotex Cold Sore Antiviral Drug Product
Table 85. Apotex Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 86. Apotex Recent Development
Table 87. Aurobindo Pharma USA, Inc. Company Details
Table 88. Aurobindo Pharma USA, Inc. Business Overview
Table 89. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product
Table 90. Aurobindo Pharma USA, Inc. Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 91. Aurobindo Pharma USA, Inc. Recent Development
Table 92. Cipla Company Details
Table 93. Cipla Business Overview
Table 94. Cipla Cold Sore Antiviral Drug Product
Table 95. Cipla Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 96. Cipla Recent Development
Table 97. Glenmark Pharmaceuticals, Inc. Company Details
Table 98. Glenmark Pharmaceuticals, Inc. Business Overview
Table 99. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product
Table 100. Glenmark Pharmaceuticals, Inc. Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 101. Glenmark Pharmaceuticals, Inc. Recent Development
Table 102. Hikma Pharmaceuticals Company Details
Table 103. Hikma Pharmaceuticals Business Overview
Table 104. Hikma Pharmaceuticals Cold Sore Antiviral Drug Product
Table 105. Hikma Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 106. Hikma Pharmaceuticals Recent Development
Table 107. HRA Pharma Company Details
Table 108. HRA Pharma Business Overview
Table 109. HRA Pharma Cold Sore Antiviral Drug Product
Table 110. HRA Pharma Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 111. HRA Pharma Recent Development
Table 112. Hetero Healthcare Ltd Company Details
Table 113. Hetero Healthcare Ltd Business Overview
Table 114. Hetero Healthcare Ltd Cold Sore Antiviral Drug Product
Table 115. Hetero Healthcare Ltd Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 116. Hetero Healthcare Ltd Recent Development
Table 117. Jubilant Cadista Company Details
Table 118. Jubilant Cadista Business Overview
Table 119. Jubilant Cadista Cold Sore Antiviral Drug Product
Table 120. Jubilant Cadista Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 121. Jubilant Cadista Recent Development
Table 122. Merix Pharmaceutical Corp Company Details
Table 123. Merix Pharmaceutical Corp Business Overview
Table 124. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product
Table 125. Merix Pharmaceutical Corp Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 126. Merix Pharmaceutical Corp Recent Development
Table 127. Sun Pharmaceutical Industries Ltd. Company Details
Table 128. Sun Pharmaceutical Industries Ltd. Business Overview
Table 129. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product
Table 130. Sun Pharmaceutical Industries Ltd. Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 131. Sun Pharmaceutical Industries Ltd. Recent Development
Table 132. Viatris Company Details
Table 133. Viatris Business Overview
Table 134. Viatris Cold Sore Antiviral Drug Product
Table 135. Viatris Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 136. Viatris Recent Development
Table 137. Wockhardt Company Details
Table 138. Wockhardt Business Overview
Table 139. Wockhardt Cold Sore Antiviral Drug Product
Table 140. Wockhardt Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 141. Wockhardt Recent Development
Table 142. Zydus Pharmaceuticals Company Details
Table 143. Zydus Pharmaceuticals Business Overview
Table 144. Zydus Pharmaceuticals Cold Sore Antiviral Drug Product
Table 145. Zydus Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
Table 146. Zydus Pharmaceuticals Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report


List of Figures
Figure 1. Cold Sore Antiviral Drug Picture
Figure 2. Global Cold Sore Antiviral Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cold Sore Antiviral Drug Market Share by Type: 2024 VS 2031
Figure 4. Smear Features
Figure 5. Oral Features
Figure 6. Others Features
Figure 7. Global Cold Sore Antiviral Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Cold Sore Antiviral Drug Market Share by Application: 2024 VS 2031
Figure 9. Child Case Studies
Figure 10. Aldult Case Studies
Figure 11. Cold Sore Antiviral Drug Report Years Considered
Figure 12. Global Cold Sore Antiviral Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cold Sore Antiviral Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cold Sore Antiviral Drug Market Share by Region: 2024 VS 2031
Figure 15. Global Cold Sore Antiviral Drug Market Share by Players in 2024
Figure 16. Global Top Cold Sore Antiviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Sore Antiviral Drug as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cold Sore Antiviral Drug Revenue in 2024
Figure 18. North America Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cold Sore Antiviral Drug Market Share by Country (2020-2031)
Figure 20. United States Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cold Sore Antiviral Drug Market Share by Country (2020-2031)
Figure 24. Germany Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cold Sore Antiviral Drug Market Share by Region (2020-2031)
Figure 32. China Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cold Sore Antiviral Drug Market Share by Country (2020-2031)
Figure 40. Mexico Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cold Sore Antiviral Drug Market Share by Country (2020-2031)
Figure 44. Turkey Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 48. Ortho Dermatologics Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 49. Foundation Consumer Healthcare Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 52. Amneal Pharmaceuticals LLC Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 53. AiCuris Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 54. Apotex Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 55. Aurobindo Pharma USA, Inc. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 56. Cipla Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 57. Glenmark Pharmaceuticals, Inc. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 58. Hikma Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 59. HRA Pharma Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 60. Hetero Healthcare Ltd Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 61. Jubilant Cadista Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 62. Merix Pharmaceutical Corp Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 63. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 64. Viatris Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 65. Wockhardt Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 66. Zydus Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies